|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||354.9 g/mol g·mol−1|
|3D model (JSmol)|
Zicronapine (// zye-KRON-ə-peen, previously known as Lu 31-130) is an atypical antipsychotic medication formerly under development by H. Lundbeck A/S. In phase II studies zicronapine showed statistically significant separation from placebo and convincing efficacy and safety data when compared to olanzapine.
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|
|This psychiatry-related article is a stub. You can help Wikipedia by expanding it.|